Literature DB >> 29020610

Neonatal C57BL/6J and parkin mice respond differently following developmental manganese exposure: Result of a high dose pilot study.

Melanie L Foster1, Thomas B Bartnikas2, Hailey C Maresca-Fichter3, Courtney Mercadante4, Miriam Dash5, Chelsea Miller6, David C Dorman7.   

Abstract

It has been suggested that childhood exposure to neurotoxicants may increase the risk of Parkinson's disease (PD) or other neurodegenerative disease in adults. Some recessive forms of PD have been linked to loss-of-function mutations in the Park2 gene that encodes for parkin. The purpose of this pilot study was to evaluate whether responses to neonatal manganese (Mn) exposure differ in mice with a Park2 gene defect (parkin mice) when compared with a wildtype strain (C57BL/6J). Neonatal parkin and C57BL/6J littermates were randomly assigned to 0, 11, or 25mg Mn/kg-day dose groups with oral exposures occurring from postnatal day (PND) 1 through PND 28. Motor activity was measured on PND 19-22 and 29-32. Tissue Mn concentrations were measured in liver, femur, olfactory bulb, frontal cortex, and striatum on PND 29. Hepatic and frontal cortex gene expression of Slc11a2, Slc40a1, Slc30a10, Hamp (liver only), and Park2 were also measured on PND 29. Some strain differences were seen. As expected, decreased hepatic and frontal cortex Park2 expression was seen in the parkin mice when compared with C57BL/6J mice. Untreated parkin mice also had higher liver and femur Mn concentrations when compared with the C57BL/6J mice. Exposure to≥11mg Mn/kg-day was associated with increased brain Mn concentrations in all mice, no strain difference was observed. Manganese exposure in C57Bl6, but not parkin mice, was associated with a negative correlation between striatal Mn concentration and motor activity. Manganese exposure was not associated with changes in frontal cortex gene expression. Decreased hepatic Slc30a10, Slc40a1, and Hamp expression were seen in PND 29 C57BL/6J mice given 25mg Mn/kg-day. In contrast, Mn exposure was only associated with decreased Hamp expression in the parkin mice. Our results suggest that the Parkin gene defect did not increase the susceptibility of neonatal mice to adverse health effects associated with high-dose Mn exposure.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Manganese; Metabolism; Neurotoxicity; Pharmacokinetics

Mesh:

Substances:

Year:  2017        PMID: 29020610      PMCID: PMC6250062          DOI: 10.1016/j.neuro.2017.10.002

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  59 in total

Review 1.  What genetics tells us about the causes and mechanisms of Parkinson's disease.

Authors:  Olga Corti; Suzanne Lesage; Alexis Brice
Journal:  Physiol Rev       Date:  2011-10       Impact factor: 37.312

2.  Ferroportin deficiency impairs manganese metabolism in flatiron mice.

Authors:  Young Ah Seo; Marianne Wessling-Resnick
Journal:  FASEB J       Date:  2015-03-17       Impact factor: 5.191

3.  Manganese-induced developmental neurotoxicity in the CD rat: is oxidative damage a mechanism of action?

Authors:  K A Brenneman; R C Cattley; S F Ali; D C Dorman
Journal:  Neurotoxicology       Date:  1999 Apr-Jun       Impact factor: 4.294

Review 4.  Hepcidin--a regulator of intestinal iron absorption and iron recycling by macrophages.

Authors:  Tomas Ganz
Journal:  Best Pract Res Clin Haematol       Date:  2005-06       Impact factor: 3.020

5.  The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.

Authors:  Adriana Donovan; Christine A Lima; Jack L Pinkus; Geraldine S Pinkus; Leonard I Zon; Sylvie Robine; Nancy C Andrews
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

Review 6.  Paraquat and Parkinson's disease.

Authors:  C Berry; C La Vecchia; P Nicotera
Journal:  Cell Death Differ       Date:  2010-01-22       Impact factor: 15.828

Review 7.  Speciation and toxicological relevance of manganese in humans.

Authors:  Bernhard Michalke; Stefan Halbach; Volker Nischwitz
Journal:  J Environ Monit       Date:  2007-06-07

8.  Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity.

Authors:  Keith M Erikson; David C Dorman; Lawrence H Lash; Michael Aschner
Journal:  Toxicol Sci       Date:  2007-03-07       Impact factor: 4.849

Review 9.  Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology.

Authors:  Tina Skjørringe; Annette Burkhart; Kasper Bendix Johnsen; Torben Moos
Journal:  Front Mol Neurosci       Date:  2015-06-08       Impact factor: 5.639

10.  Liver metal levels and expression of genes related to iron homeostasis in rhesus monkeys after inhalational manganese exposure.

Authors:  Michael A Pettiglio; Carolina Herrera; Melanie L Foster; David C Dorman; Thomas B Bartnikas
Journal:  Data Brief       Date:  2016-02-08
View more
  1 in total

1.  Interactions of manganese with iron, zinc, and copper in neonatal C57BL/6J and parkin mice following developmental oral manganese exposure.

Authors:  Melanie L Foster; Thomas B Bartnikas; Hailey C Maresca-Fichter; Courtney Mercadante; Miriam Dash; Chelsea Miller; David C Dorman
Journal:  Data Brief       Date:  2017-10-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.